| Autor: |
Finkeistein, Stan N., Sinskey, Anthony J., Cooper, Scott M. |
| Zdroj: |
PharmaGenomics; May2004, Vol. 4 Issue 4, p20-24, 3p |
| Abstrakt: |
This article discusses about the use of molecular imaging in drug development and discovery; whether it can improve drug development process or not, in what specific activities could it be more useful. It explores issues related to medical imaging at the molecular level. The goal is to develop technologies and assays for imaging molecular and cellular events in living organisms. Accelerating pre-clinical drug development is one of the key areas of locus for scientists involved in molecular imaging. Problems in pre-clinical drug development have been addressed through advances in molecular imaging. One of the keys to molecular imaging's value in drug development is probes, which provide the imaging signal or image contrast in most molecular imaging assays. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
